News on Zebinix in children with focal epilepsy from the EPNS
New Marketing Authorisation for Zebinix®
Press release on behalf of Bial and Eisai
Documentary: Andrew Lees – Mentored by a Madman
Watch our documentary about Professor Andrew Lees
COPAXONE® no longer contraindicated during pregnancy in the UK
Industry News from Teva Pharma
EC grants Marketing Authorisation for Zebinix® for the treatment of partial-onset seizures in children
Industry news from Bial and Eisai
Life After Encephalitis: Ross’s Story
Ross’s story: An excerpt from “Life after Encephalitis” by Dr Ava Easton.
The Encephalitis Society
Dr Ava Easton
New Dementia interactive care pathway toolkit now available
Sarah Gillett, Managing Director, Neurology Academy
Sponsored Article
STADA Australia continues to innovate in Parkinson’s Disease with MOVAPO® pre-filled syringes (PFS) Parkinson’s Disease is a surprisingly prevalent condition with an estimated 10 million people worldwide and roughly 70,000 Australians (1 in every 340 people) suffering from the condition.1 It is the second most prevalent neurological condition exceeded only by dementia. It is more common…